Home
DERM
DERM News

Latest Journey Medical Corporation (DERM) News on February 23, 2025

Journey Medical Corporation (DERM): A Bull Case Theory

Insider Monkey

2 days ago

Journey Medical Corporation (DERM): A Bull Case Theory

Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week

Simply Wall St.

18 days ago

Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week

Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)

Insider Monkey

a month ago

Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

GlobeNewswire

a month ago

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Despite Journey Medical's Pullback, Insiders Still Gained US$118k

Simply Wall St.

3 months ago

Despite Journey Medical's Pullback, Insiders Still Gained US$118k

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates

Zacks

3 months ago

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

3 months ago

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

FDA approves Journey Medical’s rosacea treatment Emrosi

Pharmaceutical Technology

4 months ago

FDA approves Journey Medical’s rosacea treatment Emrosi

MT Newswires

4 months ago

Journey Medical Gets FDA Approval for Rosacea Treatment

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?

Zacks

4 months ago

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

GlobeNewswire

4 months ago

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

GlobeNewswire

4 months ago

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

ACCESSWIRE

4 months ago

SWK Holdings Provides Portfolio Update

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GlobeNewswire

5 months ago

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?

Simply Wall St.

5 months ago

Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

GlobeNewswire

5 months ago

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

6 months ago

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Journey Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Journey Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Journey Medical Corporation (NASDAQ:DERM) Just Reported And Analysts Have Been Lifting Their Price Targets

Simply Wall St.

6 months ago

Journey Medical Corporation (NASDAQ:DERM) Just Reported And Analysts Have Been Lifting Their Price Targets

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

6 months ago

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates

Zacks

6 months ago

Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

6 months ago

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates

Zacks

6 months ago

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

GlobeNewswire

7 months ago

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

ACCESSWIRE

7 months ago

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?

Zacks

7 months ago

4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

GlobeNewswire

7 months ago

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week

Simply Wall St.

8 months ago

Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

GlobeNewswire

9 months ago

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

GuruFocus.com

9 months ago

Journey Medical Corp (DERM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Growth ...

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

9 months ago

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

GlobeNewswire

10 months ago

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

GlobeNewswire

10 months ago

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

ACCESSWIRE

10 months ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

GlobeNewswire

10 months ago

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)

GuruFocus.com

a year ago

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)

Journey Medical Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

a year ago

Journey Medical Full Year 2023 Earnings: EPS Misses Expectations

Thomson Reuters StreetEvents

a year ago

Q4 2023 Journey Medical Corp Earnings Call

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

a year ago

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA

Zacks

a year ago

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

GlobeNewswire

a year ago

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

GlobeNewswire

a year ago

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

GlobeNewswire

a year ago

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

GlobeNewswire

a year ago

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Journey Medical Insiders Up US$187k On US$520.8k Investment

Simply Wall St.

a year ago

Journey Medical Insiders Up US$187k On US$520.8k Investment

Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?

Zacks

a year ago

Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Zacks

a year ago

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share

GlobeNewswire

a year ago

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

PR Newswire

a year ago

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

Bay Commercial Bank (BCML) Lags Q4 Earnings Estimates

Zacks

a year ago

Bay Commercial Bank (BCML) Lags Q4 Earnings Estimates

West Bancorp Inc (WTBA) Reports Decline in Annual Net Income Amid Margin Challenges

GuruFocus.com

a year ago

West Bancorp Inc (WTBA) Reports Decline in Annual Net Income Amid Margin Challenges

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union

PR Newswire

a year ago

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union

American Superconductor (AMSC) Q3 Earnings and Revenues Top Estimates

Zacks

a year ago

American Superconductor (AMSC) Q3 Earnings and Revenues Top Estimates

Standard Lithium Advances South West Arkansas Project: Definitive Feasibility Study and Front-End Engineering Design Firm Chosen

GlobeNewswire

a year ago

Standard Lithium Advances South West Arkansas Project: Definitive Feasibility Study and Front-End Engineering Design Firm Chosen

LivePerson Adopts Tax Benefits Preservation Plan To Protect Valuable Tax Assets

PR Newswire

a year ago

LivePerson Adopts Tax Benefits Preservation Plan To Protect Valuable Tax Assets

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

GlobeNewswire

a year ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

Genetron Health to Hold Extraordinary General Meeting of Shareholders

GlobeNewswire

a year ago

Genetron Health to Hold Extraordinary General Meeting of Shareholders

FAT Brands Makes West Coast Debut of Co-Branded Johnny Rockets and Hurricane Wings

GlobeNewswire

a year ago

FAT Brands Makes West Coast Debut of Co-Branded Johnny Rockets and Hurricane Wings

Franklin Covey Co. (NYSE:FC) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Franklin Covey Co. (NYSE:FC) Q1 2024 Earnings Call Transcript

Are Consumer Staples Stocks Lagging Coca-Cola (KO) This Year?

Zacks

a year ago

Are Consumer Staples Stocks Lagging Coca-Cola (KO) This Year?

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

GlobeNewswire

a year ago

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors

GlobeNewswire

a year ago

Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors

Business Wire

a year ago

Southland Awarded RFK Bridge Rehab & Other New Projects Totaling $470 Million

Ellomay Capital Enters into an Agreement to Sell the Talmei Yosef Solar Facility

PR Newswire

a year ago

Ellomay Capital Enters into an Agreement to Sell the Talmei Yosef Solar Facility

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

GlobeNewswire

a year ago

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

Are Investors Undervaluing Galiano Gold (GAU) Right Now?

Zacks

a year ago

Are Investors Undervaluing Galiano Gold (GAU) Right Now?

Smith-Midland Appoints New Members to its Board of Directors

ACCESSWIRE

a year ago

Smith-Midland Appoints New Members to its Board of Directors

Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength

Zacks

a year ago

Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics

Zacks

a year ago

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics

What Awaits These 4 Drug Stocks That More Than Doubled in 2023?

Zacks

a year ago

What Awaits These 4 Drug Stocks That More Than Doubled in 2023?

Owning 44% shares,institutional owners seem interested in Smith-Midland Corporation (NASDAQ:SMID),

Simply Wall St.

a year ago

Owning 44% shares,institutional owners seem interested in Smith-Midland Corporation (NASDAQ:SMID),

Why CommScope Stock Was on Fire Today

Motley Fool

a year ago

Why CommScope Stock Was on Fire Today

argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study

Zacks

a year ago

argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study

IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial

GlobeNewswire

a year ago

IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial

GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION

PR Newswire

a year ago

GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION

Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA

Zacks

a year ago

Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA

4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow

Zacks

a year ago

4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow

ESSA Bancorp Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

a year ago

ESSA Bancorp Full Year 2023 Earnings: Beats Expectations

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Zacks

a year ago

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Smith-Midland Receives $3.8M J-J Hooks Barrier Rental Contract for I-64 in Virginia

ACCESSWIRE

a year ago

Smith-Midland Receives $3.8M J-J Hooks Barrier Rental Contract for I-64 in Virginia

Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference

There's A Lot To Like About C&F Financial's (NASDAQ:CFFI) Upcoming US$0.44 Dividend

Simply Wall St.

a year ago

There's A Lot To Like About C&F Financial's (NASDAQ:CFFI) Upcoming US$0.44 Dividend

Upland FileBound Named a Gold Medalist in the 2023 SoftwareReviews ECM Data Quadrant Report

Business Wire

a year ago

Upland FileBound Named a Gold Medalist in the 2023 SoftwareReviews ECM Data Quadrant Report

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

GlobeNewswire

a year ago

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

American Battery Technology Company Invited to Present at Expert Battery Metals and Recycling Industry Conferences

PR Newswire

a year ago

American Battery Technology Company Invited to Present at Expert Battery Metals and Recycling Industry Conferences

Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer

GlobeNewswire

a year ago

Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer

Southland Holdings, Inc. (NYSE:SLND) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Southland Holdings, Inc. (NYSE:SLND) Q3 2023 Earnings Call Transcript

Natural Gas Services Group, Inc. Reports its Third Quarter 2023 Financial and Operating Results

GlobeNewswire

a year ago

Natural Gas Services Group, Inc. Reports its Third Quarter 2023 Financial and Operating Results

AFC Gamma, Inc. (NASDAQ:AFCG) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

AFC Gamma, Inc. (NASDAQ:AFCG) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q3 2023 AFC Gamma Inc Earnings Call

InfuSystem Holdings, Inc. (AMEX:INFU) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

InfuSystem Holdings, Inc. (AMEX:INFU) Q3 2023 Earnings Call Transcript

AFC Gamma, Inc. Announces Financial Results for Third Quarter 2023

GlobeNewswire

a year ago

AFC Gamma, Inc. Announces Financial Results for Third Quarter 2023

Investors in Semler Scientific (NASDAQ:SMLR) have unfortunately lost 51% over the last three years

Simply Wall St.

a year ago

Investors in Semler Scientific (NASDAQ:SMLR) have unfortunately lost 51% over the last three years

Share on Social Networks: